Literature DB >> 15054027

The analysis of hospital infection data using hidden Markov models.

Ben Cooper1, Marc Lipsitch.   

Abstract

Surveillance data for communicable nosocomial pathogens usually consist of short time series of low-numbered counts of infected patients. These often show overdispersion and autocorrelation. To date, almost all analyses of such data have ignored the communicable nature of the organisms and have used methods appropriate only for independent outcomes. Inferences that depend on such analyses cannot be considered reliable when patient-to-patient transmission is important. We propose a new method for analysing these data based on a mechanistic model of the epidemic process. Since important nosocomial pathogens are often carried asymptomatically with overt infection developing in only a proportion of patients, the epidemic process is usually only partially observed by routine surveillance data. We therefore develop a 'structured' hidden Markov model where the underlying Markov chain is generated by a simple transmission model. We apply both structured and standard (unstructured) hidden Markov models to time series for three important pathogens. We find that both methods can offer marked improvements over currently used approaches when nosocomial spread is important. Compared to the standard hidden Markov model, the new approach is more parsimonious, is more biologically plausible, and allows key epidemiological parameters to be estimated.

Entities:  

Mesh:

Year:  2004        PMID: 15054027     DOI: 10.1093/biostatistics/5.2.223

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  38 in total

1.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals.

Authors:  Carl T Bergstrom; Monique Lo; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205

2.  Comparative estimation of the reproduction number for pandemic influenza from daily case notification data.

Authors:  Gerardo Chowell; Hiroshi Nishiura; Luís M A Bettencourt
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

3.  Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models.

Authors:  E S McBryde; A N Pettitt; B S Cooper; D L S McElwain
Journal:  J R Soc Interface       Date:  2007-08-22       Impact factor: 4.118

4.  On methods for studying stochastic disease dynamics.

Authors:  M J Keeling; J V Ross
Journal:  J R Soc Interface       Date:  2008-02-06       Impact factor: 4.118

Review 5.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

6.  Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Authors:  Elizabeth Mostofsky; Marc Lipsitch; Gili Regev-Yochay
Journal:  J Antimicrob Chemother       Date:  2011-07-07       Impact factor: 5.790

7.  Extended models for nosocomial infection: parameter estimation and model selection.

Authors:  Alun Thomas; Karim Khader; Andrew Redd; Molly Leecaster; Yue Zhang; Makoto Jones; Tom Greene; Matthew Samore
Journal:  Math Med Biol       Date:  2018-03-16       Impact factor: 1.854

Review 8.  Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes.

Authors:  Rebecca A Pierce; Justin Lessler; Aaron M Milstone
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

9.  Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes.

Authors:  B S Cooper; G F Medley; S P Stone; C C Kibbler; B D Cookson; J A Roberts; G Duckworth; R Lai; S Ebrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

10.  Using dynamic stochastic modelling to estimate population risk factors in infectious disease: the example of FIV in 15 cat populations.

Authors:  David Fouchet; Guillaume Leblanc; Frank Sauvage; Micheline Guiserix; Hervé Poulet; Dominique Pontier
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.